The National Primary Health Care Development Agency (NPHCDA), on Monday at the weekly briefing of the presidential task force (PTF) on COVID-19 revealed that Nigeria has vaccinated 122,400 persons against the dreaded virus, just two weeks after the country began the vaccination.
This was revealed by Faisal Shuaib, the executive director of NPHCDA.
It was also revealed that “No Nigerian so far has developed any known severe side effect (of the vaccine),”
Shuaib added that there might be mild symptoms such as pain and swelling at the spot of vaccination, body pains and mild fever.
He said the vaccination has fully commenced in all states and the federal capital territory (FCT) except four: Kogi, Kebbi, Zamfara, and Oyo.
However, only Kogi is yet to receive their own supply of the vaccines.
“Kogi state was not supplied with the vaccines because their cold store is still under repairs following vandalisation during the #EndSARS protest,” the NPHCDA director said.
Nigeria administered the first dose of the Oxford-Astrazeneca vaccine on March 5 after receiving 3.9 million doses courtesy of COVAX, the global alliance against COVID-19.
However, the country has managed to administer an average of 8,100 doses daily, a slow process for a population of over 200 million citizens.